Dr. Muhammad Mustafa, M.D.
What this data tells you about Dr. Mustafa
Dr. Muhammad Mustafa is a cardiovascular disease specialist in Winter Haven, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Mustafa performed 10,068 Medicare services across 6,058 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mustafa received a total of $39,250 from 37 pharmaceutical and/or device companies across 483 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mustafa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 122984 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,811 | $91 | $218 |
| Electrocardiogram (EKG), 12-lead | 1,737 | $10 | $51 |
| Echocardiogram, transthoracic | 706 | $140 | $612 |
| EKG interpretation and report | 559 | $6 | $21 |
| Heart muscle strain imaging | 448 | $26 | $118 |
| Regadenoson injection (Lexiscan) for heart stress test | 240 | $45 | $119 |
| Blood draw (venipuncture) | 221 | $8 | $9 |
| 3d radiographic procedure | 219 | $18 | $69 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 211 | $27 | $104 |
| Prothrombin time test (blood clotting) | 202 | $4 | $9 |
| New patient office visit (45-59 min) | 202 | $119 | $333 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 195 | $16 | $45 |
| Remote pacemaker/defibrillator monitoring, 90 days | 163 | $17 | $74 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 153 | $47 | $260 |
| Hospital follow-up visit, moderate complexity | 150 | $62 | $148 |
| Initial hospital admission, moderate complexity | 140 | $103 | $283 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 136 | $196 | $384 |
| Remote pacemaker monitoring, 90 days | 125 | $23 | $97 |
| Complete blood count (CBC) with differential | 114 | $8 | $16 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 106 | $20 | $84 |
| Programming of dual lead pacemaker system | 105 | $56 | $214 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 104 | $20 | $85 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 77 | $19 | $83 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 77 | $623 | $2,035 |
| Evaluation of implantable heart and blood vessel monitoring system | 72 | $33 | $141 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 71 | $46 | $211 |
| Ultrasound of heart with probe in esophagus, with report | 70 | $83 | $346 |
| Ultrasound of heart blood flow, valves and chambers | 70 | $14 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 70 | $2 | $13 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 68 | $326 | $1,392 |
| External shock to heart to regulate heart beat | 63 | $85 | $480 |
| Lipid panel (cholesterol and triglycerides) | 48 | $13 | $27 |
| Comprehensive metabolic blood panel | 46 | $10 | $21 |
| Basic metabolic blood panel | 41 | $8 | $17 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 38 | $28 | $118 |
| Hospital follow-up visit, low complexity | 38 | $39 | $68 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 31 | $66 | $210 |
| Natriuretic peptide (heart and blood vessel protein) level | 30 | $38 | $79 |
| Programming of cardiac rhythm monitor system | 23 | $39 | $160 |
| Initial hospital admission, high complexity | 21 | $137 | $414 |
| Programming of dual lead implantable defibrillator system | 20 | $61 | $276 |
| Programming of multiple lead implantable defibrillator system | 17 | $77 | $298 |
| Hospital follow-up visit, high complexity | 17 | $94 | $213 |
| Ultrasound of both sides of head and neck blood flow | 13 | $144 | $586 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for cardiovascular disease in FL.
Geographic Context
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mustafa is a clinical cardiology specialist, with above-average Medicare volume (top 8% in FL), with speaking/promotional industry engagement in the top 9% of FL peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mustafa experienced with office visit, established patient (30-39 min)?
Does Dr. Mustafa receive payments from pharmaceutical companies?
How do Dr. Mustafa's costs compare to other cardiologists in Winter Haven?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology